WRF
MEDP icon

Waddell & Reed Financial’s Medpace MEDP Stock Holding History

Waddell & Reed Financial’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-69,121
Closed -$5.81M – 462
2019
Q3 		$5.81M Buy
69,121
+24,922
+56% +$1.88M 0.02% 417
2019
Q2 		$2.89M Buy
+44,199
New +$2.55M 0.01% 449

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Waddell & Reed Financial's MEDP Position: Q4 2019 in Review

Waddell & Reed Financial sold out of Medpace (MEDP) in Q4 2019, closing a stake of 69,121 shares — an estimated $5.81M sold.

Waddell & Reed Financial first reported a position in MEDP in Q2 2019 and held it in 2 quarters. The position peaked at $5.81M in Q3 2019. 250 funds tracked by Wall St. Rank hold MEDP as of Q4 2019.

  • Waddell & Reed Financial reported no remaining Medpace position as of Q4 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 69,121 Medpace shares in Q4 2019, an estimated $5.81M.
  • Waddell & Reed Financial first reported a position in Medpace in Q2 2019 and held it in 2 quarters.
  • Waddell & Reed Financial's Medpace position peaked at $5.81M in Q3 2019.
  • 250 funds tracked by Wall St. Rank held Medpace as of Q4 2019.

Based on Waddell & Reed Financial's 13F filing for Q4 2019, filed 14 Feb 2020.